ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,578Medicare Part D Prescriptions Filled, Including Refills

Rank: 55 out of 910

$629K Total Retail Price of All Prescriptions

Rank: 97 out of 910

997 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
18% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 997 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

13% of this provider’s 997 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 11,095 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
SIMVASTATIN 766 686 1 3
LEVOTHYROXINE SODIUM 643 605 2 1
HYDROCODONE-ACETAMINOPHEN 461 381 S3 3 8
LISINOPRIL 415 362 4 2
OMEPRAZOLE 363 334 5 5
METFORMIN HCL 338 276 6 6
AMLODIPINE BESYLATE 284 262 7 4
FLUTICASONE PROPIONATE 258 217 8 23
ATENOLOL 241 214 9 10
GLIPIZIDE 201 182 10 38
WARFARIN SODIUM 191 173 11 11
ENALAPRIL MALEATE 189 161 12 60
CITALOPRAM HBR 187 165 13 19
FUROSEMIDE 187 184 13 9
ZOLPIDEM TARTRATE 181 169 15 17
METOPROLOL TARTRATE 171 150 16 7
LISINOPRIL-HYDROCHLOROTHIAZIDE 159 159 17 44
LOSARTAN POTASSIUM 153 151 18 15
TERAZOSIN HCL 151 151 19 61
HYDROCHLOROTHIAZIDE 149 128 20 12
ALENDRONATE SODIUM 144 142 21 22
RANITIDINE HCL 143 118 22 28
METOPROLOL SUCCINATE 141 127 23 21
SERTRALINE HCL 134 101 24 24
ALLOPURINOL 133 131 25 33
OXYCODONE-ACETAMINOPHEN 129 93 S2 26 31
TRAZODONE HCL 124 77 27 37
PANTOPRAZOLE SODIUM 123 106 28 27
PREDNISONE 122 119 29 43
GABAPENTIN 104 80 30 13
LOSARTAN-HYDROCHLOROTHIAZIDE 96 83 31 79
CARVEDILOL 94 85 32 36
ZETIA 93 88 33 84
LOVASTATIN 93 77 33 20
PLAVIX 87 73 35 53
ADVAIR DISKUS 82 82 36 45
DOXAZOSIN MESYLATE 79 75 37 62
KLOR-CON 10 78 74 38 88
NAPROXEN 77 54 39 96
ATORVASTATIN CALCIUM 76 70 40 14
CYCLOBENZAPRINE HCL 73 48 R 41 80
CLOPIDOGREL 72 63 42 35
DIGOXIN 71 61 43 64
GEMFIBROZIL 70 64 44 63
METFORMIN HCL ER 69 64 45 77
POTASSIUM CHLORIDE 69 63 45 18
PAROXETINE HCL 66 64 47 50
TRAMADOL HCL 64 57 48 25
CELEBREX 63 63 49 85
FLUOXETINE HCL 59 52 50 49
TAMSULOSIN HCL 58 55 51 29
PROAIR HFA 57 42 52 40
LANTUS 57 36 52 30
DICLOFENAC SODIUM 57 44 52 116
CEPHALEXIN 56 46 55 90
NIFEDIAC CC 56 41 55 131
OXYBUTYNIN CHLORIDE ER 54 54 57 111
CRESTOR 54 50 57 26
DIOVAN 53 53 59 34
POLYETHYLENE GLYCOL 3350 53 50 59 104
ESTRADIOL 51 43 R 61 92
VERAPAMIL ER 50 46 62 99
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 18, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.